Eli Lilly: Digital Transformation Strategies
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
Elli Lilly and Company (Eli Lilly) is an American pharmaceutical company engaged in the discovery, development, manufacturing, and marketing of pharmaceutical products. The company manufactures and distributes products for cardiometabolic health, oncology, immunology, and neuroscience. Eli Lilly has drug manufacturing facilities in the US, Asia, and Europe, and it sells its products in over 95 countries. The company holds patents for hundreds of branded drugs, including Jardiance, Mounjaro/ Zepbound, Trulicity, Cyramza, Jaypirca, Retevmo, Verzenio, Olumiant, Ebglyss, Taltz, and Omvoh, among others. The company has only one business segment: human pharmaceutical products.
The report provides information and insights into Eli Lilly's tech activities, including:
• Insights of its digital transformation strategies and innovation programs.
• Overview of technology initiatives covering partnerships, product launches, and investments.
• Insights on each technology initiative including technology theme, objective, and benefits.
• Details of estimated ICT budgets.
Scope
The report provides insights into the company’s tech activities, including its digital transformation strategies, its innovation programs, its technology initiatives, and its investments.
Reasons to Buy
Gain insights into Eli Lilly's tech operations.
Gain insights into its tech strategies and innovation initiatives.
Gain insights into its technology themes under focus.
Gain insights into various product launches, partnerships, and investments
BigHat Biosciences
Welldoc
Superluminal Medicines
OpenAI
Isomorphic Labs
insitro
Genetic Leap
XtalPi
Yseop
Verge Genomics
Tredence
JD Health
Amazon Pharmacy
Strateos
Salesforce
HiveMQ
Persist AI
Table of Contents
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Related reports
View more Pharmaceuticals and Healthcare reports